Panel Discussion: Moving from Broad CKD to Precision Nephrology to Match the Right Mechanism to the Right Patient at the Right Time
9:30 am - Wednesday 17th March 2027
- Segmenting heterogeneous CKD populations according to biology, genetics, progression and therapeutic response
- Determining how far patient populations can be narrowed before development becomes operationally impractical
- Connecting patient stratification with mechanism selection, trial design and eventual treatment decisions